ADVFN US – Market Content Editor
-
Gold Rebounds from Recent Lows as Trade Tensions Escalate; U.S. Copper Crashes
Gold prices recovered in Thursday’s Asian session, bouncing off one-month lows as investors sought refuge from escalating trade tensions tied to looming U.S. tariffs. Growing anxiety ahead of President Donald Trump’s August 1 deadline for new trade levies reignited interest in the precious metal. However, gold’s upside was restrained by the Federal Reserve’s latest policy…
-
Oil Prices Stall as China’s Economic Weakness Offsets Trump-Driven Supply Fears
Oil prices held steady in Asian trading on Thursday, erasing early gains, as concerns over weakening demand in China outweighed recent geopolitical supply risks driven by former U.S. President Donald Trump’s aggressive trade rhetoric. Crude markets initially rose for a third straight session on the back of fears that global oil supply may tighten. Trump’s…
-
Dow Jones, S&P, Nasdaq, Futures, Tech Titans Lift Wall Street, Fed Holds Steady, and Trump Seals South Korea Trade Pact
Markets rallied on Thursday, driven by stellar earnings from Meta Platforms and Microsoft that helped counterbalance the Federal Reserve’s decision to leave interest rates unchanged. Meanwhile, President Donald Trump revealed a new trade agreement with South Korea, just days ahead of a key tariff deadline. Futures Jump as Mega-Cap Techs Impress Stock futures in the…
-
Meta Platforms Jumps Premarket as Ad Revenue Surges and AI Bets Gain Momentum
Meta Platforms (NASDAQ:META) saw its shares soar in premarket trading on Thursday following a strong second-quarter earnings report driven by robust performance in its advertising segment and growing optimism around its artificial intelligence investments. The company posted a 22% year-over-year revenue increase to $47.5 billion for the April-to-June quarter, with net income reaching $18.3 billion—both…
-
Stock Market Today: S&P 500 Slips as Fed Holds Rates Steady Amid Internal Divide
The S&P 500 closed lower Wednesday as the Federal Reserve left interest rates unchanged, even as two policymakers dissented—the first double dissent since 1993—highlighting growing divisions over the future of monetary policy. At the 4:00 p.m. ET close, the Dow Jones Industrial Average gained 171 points, or 0.4%, the S&P 500 slipped 0.1%, and the…
-
U.S. Stocks Finish Narrowly Mixed Ahead of Major Earnings Reports
Following the modest pullback seen in the previous session, stocks showed a lack of direction over the course of the trading day on Wednesday. The major averages spent the day bouncing back and forth across the unchanged line before closing narrowly mixed. While the tech-heavy Nasdaq rose 31.38 points or 0.2 percent to 21,129.67, the…
-
Logitech CEO says company is on track to cut China production amid U.S. tariffs
Logitech International (NASDAQ:LOGI) is making strong progress in shifting manufacturing away from China to reduce exposure to U.S. tariffs, CEO Hanneke Faber stated Wednesday. The company aims to bring the share of products destined for the U.S. that are made in China down to 10% by year-end, having already lowered it from 40% to just…
-
Meta’s Zuckerberg says ‘superintelligence’ is now within reach
Mark Zuckerberg, CEO of Meta (NASDAQ:META), shared his vision for delivering “personal superintelligence” to everyone, setting Meta’s AI strategy apart from its rivals. In a statement released Wednesday, Zuckerberg revealed that Meta’s AI systems have started to show signs of self-improvement, making the arrival of superintelligence “now in sight” over the coming years. “Meta’s vision…
-
Federal Signal shares jump after Q2 earnings surpass estimates
Federal Signal Corporation (NYSE:FSS) saw its shares rise 5% in premarket trading after reporting second-quarter earnings that beat analyst expectations and prompting the company to raise its full-year guidance. The provider of environmental and safety solutions posted adjusted earnings per share of $1.17 for the quarter ended June 30, topping the analyst consensus of $1.06.…
-
LENZ Therapeutics shares climb as FDA review of presbyopia treatment stays on schedule
LENZ Therapeutics, Inc. (NASDAQ:LENZ) saw its stock rise 6.1% in premarket trading following the release of its second-quarter financial report and confirmation that the FDA’s decision on its New Drug Application (NDA) for LNZ100 remains on track for August 8, 2025. The biopharmaceutical company, currently in the pre-commercial phase, posted a second-quarter loss of $0.53…